Literature DB >> 9018762

Expression of mRNA for interferon-gamma, interleukin-10, and interleukin-12 (p40) in normal gastric mucosa and in mucosa infected with Helicobacter pylori.

R A Karttunen1, T J Karttunen, M M Yousfi, H M el-Zimaity, D Y Graham, F A el-Zaatari.   

Abstract

BACKGROUND: We studied the mRNA expressions of interferon-gamma (IFN-gamma), interleukin-10 (IL-10), and IL-12 in gastric biopsy and blood samples from patients with and without Helicobacter pylori infection, by reverse-transcription polymerase chain reaction (RT-PCR).
METHODS: RT-PCR was performed on total RNA preparations, and the expressed mRNA were semiquantitated on the basis of band intensities on Southern blots.
RESULTS: In gastric mucosa the expression of IFN-gamma and IL-10 was found in most patients with and without H. pylori infection, whereas IL-12 was found in most of the infected ones. The level of IFN-gamma and IL-10 did not differ between groups, whereas the IL-12 level was significantly higher in those with H. pylori infection. In the blood IFN-gamma expression was found in most samples, with higher level in patients with gastritis than in normals. Few blood samples (33%) had IL-12, and none had IL-10.
CONCLUSION: IFN-gamma and IL-10 expressions in healthy mucosa may indicate a biologic role in a healthy state. IL-12 expression in mucosa was related to the presence of bacterial stimulant and therefore resembles proinflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9018762     DOI: 10.3109/00365529709025058

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  22 in total

Review 1.  Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development.

Authors:  Y Zevering; L Jacob; T F Meyer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration.

Authors:  N Hida; T Shimoyama; P Neville; M F Dixon; A T Axon; T Shimoyama; J E Crabtree
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

3.  Cytokine expression and production by purified Helicobacter pylori urease in human gastric epithelial cells.

Authors:  T Tanahashi; M Kita; T Kodama; Y Yamaoka; N Sawai; T Ohno; S Mitsufuji; Y P Wei; K Kashima; J Imanishi
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Lipoic acid stimulates cAMP production via G protein-coupled receptor-dependent and -independent mechanisms.

Authors:  Sonemany Salinthone; Robynn V Schillace; Catherine Tsang; John W Regan; Dennis N Bourdette; Daniel W Carr
Journal:  J Nutr Biochem       Date:  2010-10-30       Impact factor: 6.048

5.  Production of IL-12 in gastritis relates to infection with Helicobacter pylori.

Authors:  J Bauditz; M Ortner; M Bierbaum; G Niedobitek; H Lochs; S Schreiber
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

6.  Effects of cytokines, without and with Helicobacter pylori components, on mucus secretion by cultured gastric epithelial cells.

Authors:  S Takahashi; E Nakamura; S Okabe
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

7.  Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection.

Authors:  R Rad; A Dossumbekova; B Neu; R Lang; S Bauer; D Saur; M Gerhard; C Prinz
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

8.  Levels of interleukin-18 are markedly increased in Helicobacter pylori-infected gastric mucosa among patients with specific IL18 genotypes.

Authors:  Kyoko Sakai; Masakazu Kita; Naoki Sawai; Satoshi Shiomi; Yoshio Sumida; Kazuyuki Kanemasa; Shoji Mitsufuji; Jiro Imanishi; Yoshio Yamaoka
Journal:  J Infect Dis       Date:  2008-06-15       Impact factor: 5.226

9.  Antrum- and corpus mucosa-infiltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype.

Authors:  F Sommer; G Faller; P Konturek; T Kirchner; E G Hahn; J Zeus; M Röllinghoff; M Lohoff
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

10.  A comparative proteomic approach using metabolic pathways for the identification of potential drug targets against Helicobacter pylori.

Authors:  Reaz Uddin; Waqar Khalil
Journal:  Genes Genomics       Date:  2020-03-19       Impact factor: 1.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.